Treatment of cancer with novel anti-il 13 monoclonal antibodies

Details Treatment of cancer with novel anti-il 13 monoclonal antibodies Treatment of cancer with novel anti-il 13 monoclonal antibodies

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) G01N 33/574 (2006.01) C07K 16/24 (2006.01)

Patent

CA 2551110

The present invention relates to the treatment of IL13 dependent neoplastic disorders comprising the administration of novel anti-IL13 antibodies, The invention aiso includes diagnosing such tumors or cancer using the antibodies of the present invention to detect overexpression of IL13 in the patient.

L'invention porte sur le traitement de troubles néoplastiques qui dépendent de IL13, consistant à administrer de nouveaux anticorps anti-IL13. Cette invention se rapporte également au diagnostic de tumeurs ou du cancer au moyen des anticorps susmentionnés afin de détecter la surexpression de IL13 chez un patient.

Affiliated with

Also associated with

Rating

Treatment of cancer with novel anti-il 13 monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cancer with novel anti-il 13 monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer with novel anti-il 13 monoclonal antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1546073